Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be ...